Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01041196 · ClinicalTrials.gov registry record
Perforated Marginal Ulcer After Gastric Bypass
A clinical trial of Marginal Ulcer and Ulcer Disease After Gastric Bypass, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT01041196: Completed study of Marginal Ulcer and Ulcer Disease After Gastric Bypass, sponsored by University of California, San Francisco.
NCT01041196 is a study of Marginal Ulcer and Ulcer Disease After Gastric Bypass that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01041196, a study of Marginal Ulcer and Ulcer Disease After Gastric Bypass, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A common late complication after gastric bypass surgery is marginal ulceration that is defined as ulcers at the margins of the gastrojejunostomy, mostly on the jejunal side. Most marginal ulcers respond to medical therapy and complicated or complex ulcer disease warrants operative intervention; specifically, perforated, penetrated, obstructing, bleeding and intractable marginal ulcers require surgical intervention. Diverse operative strategies for addressing perforated marginal ulcers after gastric bypass have been described including I) Omental (Graham) patch repair, II) Revision of gastrojejunostomy, III) Irrigation and drainage, IV) any previous procedure with truncal vagotomy, V) Esophagojejunostomy, and VI) Reversal. We formally analyze our experience with the laparoscopic resection and repair of acutely perforated marginal ulcers after Roux-en-Y gastric bypass (RYGB), with or without concomitant resolution of technical risk factors for marginal ulceration.
Conditions Studied
Study Locations (1)
California
- UCSF Fresno Center for Medical Education and Research - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-12 |
What the finished NCT01041196 record still lists
NCT01041196 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 4 conditions, with Marginal Ulcer appearing as the primary indexed condition, and to 0 interventions.
NCT01041196 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01041196 about?
NCT01041196 is a clinical study titled "Perforated Marginal Ulcer After Gastric Bypass". A common late complication after gastric bypass surgery is marginal ulceration that is defined as ulcers at the margins of the gastrojejunostomy, mostly on the jejunal side. Most marginal ulcers respond to medical therapy and complicated or complex ulcer disease warrants operative intervention; spec...
What is the current status of trial NCT01041196?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-01. Estimated completion is 2009-12.
What conditions does trial NCT01041196 study?
This clinical trial studies the following conditions: Marginal Ulcer, Ulcer Disease After Gastric Bypass, Perforated Marginal Ulcer, Acutely Perforated Marginal Ulcer.
Who is sponsoring clinical trial NCT01041196?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01041196 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marginal Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia